Three efficacy endpoints were tested for noninferiority : ( @ ) primary composite endpoint at @-@ hours ( cessation of spreading or reduction in lesion size , absence of fever , and no rescue antibiotic ) ; ( @ ) investigator-assessed clinical cure @-@ days after end of treatment ; and ( @ ) @ % reduction in lesion area at @-@ hours .